APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Aptevo Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.60−0.02 (-1.23%)
Close on Oct 19, 2026
- Market cap
- $1.91M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2.8%
0M of 2M shares
Institutional holders
9
1 new, 0 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $20.13K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Heights Capital Management, Inc. | 83,854 | 6.30% | 13G (passive) amendment | Jun 30, 2026 |
| CVI Investments, Inc. | 83,854 | 8.20% | 13G (passive) amendment | Dec 31, 2025 |
| Waqas Khatri | 358,150 | 10.00% | 13G (passive) | Jun 30, 2025 |
| Mark Angelo | 357,842 | 9.99% | 13G (passive) | Jun 16, 2025 |
| Bigger Michael | 285,000 | 9.95% | 13G (passive) | Jun 18, 2025 |
| Bigger Capital Fund L P | 200,000 | 6.20% | 13G (passive) | Apr 3, 2025 |
| Niowave, Inc. | 151,723 | 12.20% | 13G (passive) | May 25, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of APVO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Gsa Capital Partners Llp | 21,539 | 1.20% | $96 | +1,901 | 0.01% |
| Vanguard Capital Management LLC | 12,713 | 0.71% | $56.45K | – | 0.00% |
| Geode Capital Management, LLC | 10,821 | 0.60% | $48.04K | −2,516 | 0.00% |
| Vanguard Fiduciary Trust Co | 4,142 | 0.23% | $18.39K | – | 0.00% |
| UBS Group AG | 730 | 0.04% | $3.24K | −2,715 | 0.00% |
| Osaic Holdings, Inc. | 360 | 0.02% | $1.60K | – | 0.00% |
| SBI Securities Co., Ltd. | 109 | 0.01% | $484 | – | 0.00% |
| Barclays PLC | 31 | 0.00% | $138 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $4 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 2.8% | 1 / 1 | 2 / 0 | 0M | 0M |
| Q1 2026 | 9 | 0M | 3.0% | 4 / 2 | 1 / 5 | 0M | 0M |
| Q4 2025 | 11 | 0M | 1.1% | 11 / 0 | 0 / 0 | 0M | 0M |
| Q1 2017 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2016 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2016 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of APVO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 12,713 | 0.71% | $56.45K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 8,901 | 0.49% | $43.70K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,548 | 0.09% | $7.60K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jeffrey G. Lamothe | President and CEO, Director | 961 | 0.05% | Aug 10, 2026 |
| Marvin L. White | Executive Chair, Director | 1,667 | 0.09% | Aug 10, 2026 |
| Daphne Taylor | SVP, CFO | 638 | 0.04% | Aug 10, 2026 |
| Dirk Huebner | SVP, CMO | 638 | 0.04% | Aug 10, 2026 |
| SoYoung Kwon | SVP, GC, BD & Corp Affairs | 638 | 0.04% | Aug 10, 2026 |
| Mary Jo Janatpour | SVP, CSO | 0 | – | May 28, 2026 |
| Daniel Abdun-Nabi | Director | 400 | 0.02% | Aug 10, 2026 |
| Barbara Lopez Kunz | Director | 400 | 0.02% | Aug 10, 2026 |
| John Niederhuber | Director | 400 | 0.02% | Aug 10, 2026 |
| Grady Grant III | Director | 1,150 | 0.06% | Aug 10, 2026 |
| Zsolt Harsanyi | Director | 400 | 0.02% | Aug 10, 2026 |
| Niowave, Inc. | 10% owner | 98,522 | 5.47% | Jun 22, 2026 |
| Of America Na Bank | 10% owner | – | – | Oct 3, 2025 |
| Bofa Securities, Inc. | 10% owner | 27 | 0.00% | Oct 3, 2025 |
| Of America Corp /De/ Bank | 10% owner | – | – | Oct 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Barbara Lopez Kunz Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Zsolt Harsanyi Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Daniel Abdun-Nabi Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Dirk Huebner SVP, CMO | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Dirk Huebner SVP, CMO | Aug 6, 2026 | Tax withholding | −156 | $4.07 | $635 | 482 |
| Jeffrey G. Lamothe President and CEO, Director | Aug 6, 2026 | Option exercise | +961 | – | – | 961 |
| Grady Grant III Director | Aug 6, 2026 | Option exercise | +400 | – | – | 1,150 |
| John Niederhuber Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Marvin L. White Executive Chair, Director | Aug 6, 2026 | Option exercise | +1,666 | – | – | 1,667 |
| Marvin L. White Executive Chair, Director | Aug 6, 2026 | Tax withholding | −406 | $4.07 | $1.65K | 1,261 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Daphne Taylor SVP, CFO | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Marvin L. White Executive Chair, Director | Jul 17, 2026 | Option exercise | +1 | – | – | 1 |
| Grady Grant III Director | Nov 10, 2025 | Buy | +13,513 | $1.49 | $20.13K | 13,514 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Jul 17, 2025 | Option exercise | +3 | – | – | 4 |
| John Niederhuber Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Daphne Taylor SVP, CFO | Jul 17, 2025 | Option exercise | +3 | – | – | 3 |
| Grady Grant III Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Marvin L. White President and CEO, Director | Jul 17, 2025 | Option exercise | +10 | – | – | 12 |
| Zsolt Harsanyi Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Barbara Lopez Kunz Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Jeffrey G. Lamothe EVP, COO | Jul 17, 2025 | Option exercise | +5 | – | – | 6 |
| Daniel Abdun-Nabi Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Daphne Taylor SVP, CFO | Mar 4, 2025 | Option exercise | +1 | – | – | 18 |
| Jeffrey G. Lamothe EVP, COO | Mar 3, 2025 | Option exercise | +2 | – | – | 36 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 3, 2025 | Option exercise | +2 | – | – | 25 |
| Marvin L. White President and CEO, Director | Mar 3, 2025 | Option exercise | +6 | – | – | 55 |
| Daphne Taylor SVP, CFO | Mar 2, 2025 | Option exercise | +2 | – | – | 17 |
| Jeffrey G. Lamothe EVP, COO | Mar 2, 2025 | Option exercise | +3 | – | – | 34 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 2, 2025 | Option exercise | +2 | – | – | 23 |
| Marvin L. White President and CEO, Director | Mar 2, 2025 | Option exercise | +8 | – | – | 49 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Aug 8, 2024 | Option exercise | +213 | – | – | 801 |
| Jeffrey G. Lamothe EVP, COO | Aug 8, 2024 | Option exercise | +42 | – | – | 894 |
| Jeffrey G. Lamothe EVP, COO | Aug 8, 2024 | Option exercise | +272 | – | – | 1,166 |
| Daphne Taylor SVP, CFO | Aug 8, 2024 | Option exercise | +158 | – | – | 576 |
| John Niederhuber Director | Jun 2, 2024 | Option exercise | +81 | – | – | 217 |
| Zsolt Harsanyi Director | Jun 2, 2024 | Option exercise | +81 | – | – | 280 |
| Grady Grant III Director | Jun 2, 2024 | Option exercise | +81 | – | – | 198 |
| Daniel Abdun-Nabi Director | Jun 2, 2024 | Option exercise | +81 | – | – | 277 |
| Barbara Lopez Kunz Director | Jun 2, 2024 | Option exercise | +81 | – | – | 198 |
| John Niederhuber Director | Jun 1, 2024 | Option exercise | +7 | – | – | 136 |
| Zsolt Harsanyi Director | Jun 1, 2024 | Option exercise | +7 | – | – | 199 |
| Grady Grant III Director | Jun 1, 2024 | Option exercise | +7 | – | – | 117 |
| Daniel Abdun-Nabi Director | Jun 1, 2024 | Option exercise | +7 | – | – | 196 |
| Barbara Lopez Kunz Director | Jun 1, 2024 | Option exercise | +7 | – | – | 117 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | May 31, 2024 | Option exercise | +42 | – | – | 588 |
| Daphne Taylor SVP, CFO | Mar 4, 2024 | Option exercise | +1,584 | – | – | 18,411 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 3, 2024 | Option exercise | +3,667 | – | – | 24,042 |
| Jeffrey G. Lamothe EVP, COO | Mar 3, 2024 | Option exercise | +3,667 | – | – | 37,504 |
| Marvin L. White President and CEO, Director | Mar 3, 2024 | Option exercise | +9,584 | – | – | 67,430 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 2, 2024 | Option exercise | +3,667 | – | – | 20,375 |
| Daphne Taylor SVP, CFO | Mar 2, 2024 | Option exercise | +3,667 | – | – | 16,827 |
| Jeffrey G. Lamothe EVP, COO | Mar 2, 2024 | Option exercise | +5,500 | – | – | 33,837 |
| Marvin L. White President and CEO, Director | Mar 2, 2024 | Option exercise | +12,917 | – | – | 57,846 |
| Daphne Taylor SVP, CFO | Jan 29, 2024 | Option exercise | +792 | – | – | 13,160 |
| Jeffrey G. Lamothe EVP, COO | Jan 28, 2024 | Option exercise | +1,833 | – | – | 28,337 |
| Marvin L. White President and CEO, Director | Jan 28, 2024 | Option exercise | +4,792 | – | – | 44,929 |
| Zsolt Harsanyi Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 8,475 |
| Grady Grant III Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 4,880 |
| Barbara Lopez Kunz Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 4,880 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.